Long-Term Safety Study of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women

Clinical trial NCT03271489 · COMPLETED

Trial details

NCT number: NCT03271489
Sponsor: AbbVie
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Heavy Menstrual Bleeding Uterine Fibroids

Start date: 2017-09-13
Primary completion: 2024-06-28
Enrollment: 478

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.